Blastocystis infection has been reported to be associated with irritable bowel syndrome (IBS) 
Blastocystis is a prevalent enteric protist that can be found in patients with or without gastrointestinal symptoms. Some of the symptoms associated with Blastocystis infection include abdominal pain (88%), constipation (32%), diarrhoea (23%), alternating diarrhea and constipation (15%) and others (Qadri et al. 1989) . Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal disorder of unknown cause with symptoms that include abdominal pain (100%), constipation (24%), diarrhoea (25%) and alternating diarrhoea and constipation (46%) (Wilson et al. 2004) . Inflammatory bowel disease (IBD) is a disease of unknown cause associated with diarrhoea and colonic lesions that are identified by endoscopy (Sands 2006 , Su & Lictenstein 2006 .
Studies have shown that Blastocystis infection can be associated with IBS (Yakoob et al. 2004 , Windsor 2007 , IBD (Nagler et al. 1993 , al-Tawil et al. 1994 and chronic diarrhoea (Doyle et al. 1990 ). Traditionally, Blastocystis isolates from humans have been identified as Blastocystis hominis, however phylogenetic analysis has suggested that multiple subtypes of Blastocystis can infect humans and that they possess biomedically relevant differences (Boorom et al. 2008) . The availability of data on the subtypes of Blastocystis found in these patient groups would be of interest in understanding the significance of Blastocystis infection in chronic illness. In this study, we identify Blastocystis subtypes found in patients presenting with IBS, IBD and chronic diarrhoea in Ankara, Turkey.
pATiEnTS, MATERiALS AnD METHODS
Sources and isolation of Blastocystis -Symptomatic patients were classified as follows: (i) patients with chronic diarrhoea: individuals with diarrhoea present for two or more weeks; (ii) patients with IBD: individuals diagnosed with ulcerative colitis or Crohn's disease by sigmoidoscopy, barium enema, colonoscopy and laboratory analysis (Sands 2006 , Su & Lictenstein 2006 and (iii) patients with IBS: individuals meeting Rome criteria II who attended the gastroenterology clinic at the Gazi University School of Medicine (Talley 2006) . Faecal specimens were obtained from patients using routine procedures at the laboratory of parasitology at Gazi University from September 2005-July 2007. Faecal samples were collected from 105 symptomatic patients (female/male: 58/47, age: 43.8 ± 4.21) and 96 asymptomatic controls (female/male: 53/43, age: 45.4 ± 3.5). All stool samples were evaluated through native-lugol, trichrome and Kinyoun's acid fast-staining methods. Stool samples containing other parasites were excluded from our study. The faecal specimens were cultured in Ringer's solution containing 10% horse serum and 0.05% asparagine at 37°C. Screening for Blastocystis organisms was performed on 3-4-day-old cultures by standard light microscopy. When vacuolar or granular forms of Blastocystis were observed, they were subcultured in fresh medium (Yoshikawa et al. 2004) . After one or two subcultures, Blastocystis suspensions were centrifuged at 12,000 g for 1 min. The resulting pellet was stored at -20°C until the DNA was extracted.
Genomic DNA preparation -Genomic DNA from Blastocystis was extracted using the DNAzol kit (Invitrogen Life Technologies, Carlsbad CA, USA) following the manufacturer's instructions.
Subtyping by PCR with STS primers -Seven standardised subtype-specific STS primers were used, namely SB83 (351 bp) for subtype 1, SB340 (704 bp) for subtype 2, SB227 (526 bp) for subtype 3, SB337 (487 bp) for subtype 4, SB336 (317 bp) for subtype 5, SB332 (338 bp) for subtype 6 and SB155 (650 bp) for subtype 7 (Yoshikawa et al. 2003a) . PCR conditions and electrophoresis of PCR products was performed as previously described (Yoshikawa et al. 2000) . We adhered to the recently proposed classification nomenclature, in which Blastocystis sp. subtypes are identified as n, where n is a designation developed through phylogenetic classification by small-subunit ribosomal DNA analysis (Stensvold et al. 2007 ). Other studies have used differing classification systems, which can be converted to the standard system in some cases.
Blastocystis strains Nand II, HJ96-1, HV93-13, RN94-9, SY94-3, HJ96AS-1 and B were used as positive controls to verify correct subtyping of Blastocystis sp. subtypes 1-7 (Yoshikawa et al. 1998 (Yoshikawa et al. , 2000 (Yoshikawa et al. , 2003b .
Statistical analysis -Statistical analysis was performed using the Statistical Package for the Social Sciences 13.0 software package. Chi-square analysis was used to compare the sensitivity of detection between the culture method and the direct microscopic examination of stool. A probability value of less than 0.05 was considered statistically significant.
Ethics -The study was approved by the Gazi University, School of Medicine Local Ethical Committee. Table I summarises the Blastocystis subtypes isolated from the different patient groups. Table II provides detailed information on the symptomatic status of the patients from whom Blastocystis was isolated. By direct microscopy, we detected Blastocystis in 11 symptomatic patients and eight asymptomatic patients. Using the culture method, we detected Blastocystis in eight additional symptomatic patients and eight additional asymptomatic patients. The culture method was found to be more sensitive in the detection of Blastocystis than direct microscopic stool examination (X 2 = 99.522, df = 1, p < 0.001). Compared to the culture method, direct microscopy had a sensitivity of 57.9% in symptomatic cases and 50% in asymptomatic cases.
RESULTS
When 35 isolates were screened by PCR amplification with the STS primers, subtypes 2 and 3 were detected in all patients groups (Table I, Fig.1 ). Subtype 1 (6.2%) was only detected among the asymptomatic group. Mixed infections were detected in the asymptomatic (subtypes 1 + 2) (Fig.2) and chronic diarrhoea groups (subtypes 2 + 3).
DiSCUSSiOn
In this study, we identified Blastocystis subtypes 2 and 3 to be associated with chronic infection in both symptomatic and asymptomatic individuals. These results are similar to those reported in a study of a French population, which found most human infections to be associated with Blastocystis subtypes 1-3 (L Souppart et al. 2009, unpublished observations) . Zoonotic subtypes, such as those found in rats and wild birds (subtypes 4, 6, 7), have not been commonly found in patients with chronic infections (Boorom et al. 2008) . A prior study has found that subtype 2 is more frequently associated with asymptomatic infection (Dogruman-Al et al. 2008 ). However, researchers have not consistently reported a relationship similar to that seen in Entamoeba histolytica/dispar, in which virtually all carriers of a particular protozoan subtype are asymptomatic (Stanley 2003) .
The lack of a correlation between symptoms and subtypes suggests that host factors may play a strong role in the expression of symptoms. A similar phenomenon has been observed in E. histolytica, where the identical strain can produce asymptomatic infection in one individual and severe illness in another (Stanley 2003) . Host genetic factors that can enhance the production of infection-fighting proteins, such as TNF-α may lead to the expression of symptoms in E. histolytica infection (Stanley 2003) . A similar pattern is observed in IBS, in which patients who produce (Boorom et al. 2008 ).
The genetic diversity present in the human immunological response may allow the prevalence of E. histolytica to reach high levels in apparently healthy populations, confounding observational studies. In Egypt, 21% of healthy adults are infected with E. histolytica (Stanley 2003) . A 1987 study done by one US researcher of a population in San Francisco reported finding no correlation between symptoms and infection with E. histolytica and Giardia (Markell et al. 1984) . The same researcher found a similar result in Blastocystis and concluded that it was non-pathogenic (Udkow & Markell 1993) , suggesting the need for an objective method to assess pathogenicity. Animal models exist to study the most common enteric protozoa. Experimental infection of mice and rats with Blastocystis isolates found in humans has been reported to produce illness or death in a number of independent studies (Moe et al. 1997 , Yao et al. 2005 , Zhang et al. 2006 , Hussein et al. 2008 .
IBS and IBD are thought of as psychiatric or autoimmune diseases, therefore contemporary studies addressing their pathogenesis are of value. A study of colonic biopsies taken from IBS and IBD patients found that gastrointestinal symptoms in these diseases are a result of serine protease production (Cenac et al. 2007 ). Serine proteases become neurologically active at high levels, producing abdominal aches, muscular contractions and widespread pain. These high levels of serine proteases are not found in viral or bacterial enteritis (Gecse et al. 2008) . Proteases are produced by protozoa to degrade host immunological factors, such as IgA (Puthia et al. 2005) . Secretion of high levels of enteric anti-Blastocystis IgA has been found to be a common factor in all symptomatic, but not asymptomatic, cases of Blastocystis (Mahmoud et al. 2003) . This finding suggests that the protozoan does not attack the host, but rather that the host attacks the protozoan and that the disease is a result of the protozoan's defence mechanisms. This theory would explain why some individuals can be carriers of the organism without expressing symptoms and why researchers sometimes find that symptoms appear to be contingent on other health factors (Markell & Udkow 1986) .
The study of Blastocystis may offer a productive avenue for understanding the role of protozoan infection in prevalent unexplained chronic enteric disease, such as IBS and IBD. To facilitate such a study, it is necessary to identify the subtype of Blastocystis present in patients with IBS and IBD and to be able to understand what conditions in the host may contribute to the expression of ).
